Manuscript in draft
Any advice given is from the manufacturer and acts as a guide only
M., & Wilson, S
Published clinical trials have reported large average body weight reductions in obesity protocols, dose dependent HbA1c and weight changes in type 2 diabetes protocols, and liver fat imaging endpoints in defined substudies, which is why retatrutide is now a major reference point in modern metabolic peptide research
GLP-1 receptor agonists, including liraglutide, semaglutide and dulaglutide, have so far shown remarkable potential
This weight-regulating hormone signals fullness to the brain, delays stomach emptying and lowers blood sugar, says Rekha Kumar, chief medical officer at the medically-assisted weight loss program, Found, and practicing endocrinologist in New York City